Variable porosity of the pipeline embolization device in straight and curved vessels: a guide for optimal deployment strategy.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 24072622)

Published in AJNR Am J Neuroradiol on September 26, 2013

Authors

M Shapiro1, E Raz, T Becske, P K Nelson

Author Affiliations

1: From the Departments of Radiology, Bernard and Irene Schwartz Neurointerventional Radiology Section, (M.S., E.R., T.B., P.K.N.).

Articles by these authors

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med (1997) 4.12

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science (1996) 3.82

Treatment of intracranial aneurysms by functional reconstruction of the parent artery: the Budapest experience with the pipeline embolization device. AJNR Am J Neuroradiol (2010) 3.08

A zebrafish nanos-related gene is essential for the development of primordial germ cells. Genes Dev (2001) 2.67

The New York Islands AVM Study: design, study progress, and initial results. Stroke (2003) 2.42

Safety and efficacy of adjunctive balloon remodeling during endovascular treatment of intracranial aneurysms: a literature review. AJNR Am J Neuroradiol (2008) 2.40

Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol (2000) 2.05

Hemispheric influence on autonomic modulation and baroreflex sensitivity. Ann Neurol (2001) 1.90

Gene vaccination: plasmid DNA is more than just a blueprint. Immunol Today (1998) 1.86

Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J Immunol (1998) 1.77

Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism. Nat Biotechnol (2000) 1.76

The Drosophila embryonic midline is the site of Spitz processing, and induces activation of the EGF receptor in the ventral ectoderm. Development (1996) 1.75

Identification of tissues and patterning events required for distinct steps in early migration of zebrafish primordial germ cells. Development (1999) 1.59

Retracted DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA. Cell (2000) 1.49

Stent-supported aneurysm coiling: a literature survey of treatment and follow-up. AJNR Am J Neuroradiol (2011) 1.48

High-dose administration of nonionic contrast media: a retrospective review. Radiology (1996) 1.41

Perfusion pressure, proteinuria and the isolated perfused rat kidney. Nephron (1991) 1.40

Curative cerebrovascular reconstruction with the Pipeline embolization device: the emergence of definitive endovascular therapy for intracranial aneurysms. J Neurointerv Surg (2009) 1.28

Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunity. Eur J Immunol (2000) 1.24

Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase. Infect Immun (2001) 1.21

Spitz and Wingless, emanating from distinct borders, cooperate to establish cell fate across the Engrailed domain in the Drosophila epidermis. Development (1997) 1.15

Induction of antibodies to a kappa V region by gene immunization. J Immunol (1993) 1.11

Vg1 RBP intracellular distribution and evolutionarily conserved expression at multiple stages during development. Mech Dev (1999) 1.09

Systemic administration of immunostimulatory DNA sequences mediates reversible inhibition of Th2 responses in a mouse model of asthma. J Clin Immunol (2001) 1.07

Oligonucleotide adjuvants for T helper 1 (Th1)-specific vaccination. J Exp Med (1997) 1.07

Microbial products in allergy prevention and therapy. Allergy (2003) 1.06

Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences. Int Immunol (1999) 1.05

Complications of diagnostic cerebral angiography and tips on avoidance. Neuroimaging Clin N Am (1996) 1.03

Green fluorescent protein marks skeletal muscle in murine cell lines and zebrafish. Gene (1996) 1.02

Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2. J Appl Physiol Respir Environ Exerc Physiol (1978) 1.01

Immunostimulatory DNA is a potent mucosal adjuvant. Cell Immunol (1998) 1.00

Transforming growth factor-beta gene therapy ameliorates experimental colitis in rats. Eur J Gastroenterol Hepatol (1995) 0.98

Transumbilical catheterization of cerebral arteries. Neurosurgery (1997) 0.96

Type I interferon is required to mount an adaptive response to immunostimulatory DNA. Eur J Immunol (2001) 0.95

Immunostimulatory DNA pre-priming: a novel approach for prolonged Th1-biased immunity. Cell Immunol (1999) 0.94

DNA-based immunotherapeutics for the treatment of allergic disease. Immunol Rev (2001) 0.94

Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites. J Immunol (2001) 0.92

Wada memory disparities predict seizure laterality and postoperative seizure control. Epilepsia (1995) 0.92

Immunostimulatory DNA sequences inhibit respiratory syncytial viral load, airway inflammation, and mucus secretion. J Allergy Clin Immunol (2001) 0.92

Localization of the DER/flb protein in embryos: implications on the faint little ball lethal phenotype. Development (1990) 0.92

Reconstruction of the right anterior circulation with the Pipeline embolization device to achieve treatment of a progressively symptomatic, large carotid aneurysm. J Neurointerv Surg (2009) 0.92

Regression of Kaposi's sarcoma after intravenous immunoglobulin treatment for polymyositis. Cancer (1994) 0.91

Rapid stent-supported revascularization in acute ischemic stroke. AJNR Am J Neuroradiol (2006) 0.91

DNA-based vaccination reduces the risk of lethal anaphylactic hypersensitivity in mice. J Allergy Clin Immunol (2000) 0.91

Comment on: Stenting versus aggressive medical therapy for intracranial arterial stenosis : Chimowitz MI, Lynn MJ, Derdeyn CP, et al. N Engl J Med. 2011;365:993-1003. Clin Neuroradiol (2011) 0.89

Changing capacity for DNA excision repair in mouse embryonic cells in vitro. Exp Cell Res (1977) 0.88

Introduction to immunostimulatory DNA sequences. Springer Semin Immunopathol (2000) 0.87

Systemic or mucosal administration of immunostimulatory DNA inhibits early and late phases of murine allergic conjunctivitis. Eur J Immunol (2000) 0.86

Visual loss from arterial steal in patients with maxillofacial arteriovenous malformation. Ophthalmology (2000) 0.86

A transverse and longitudinal MR imaging voxel-based morphometry study in patients with primary cervical dystonia. AJNR Am J Neuroradiol (2010) 0.86

Immunostimulatory DNA mediates inhibition of eosinophilic inflammation and airway hyperreactivity independent of natural killer cells in vivo. J Allergy Clin Immunol (2001) 0.85

De novo aneurysm formation after stereotactic radiosurgery of a residual arteriovenous malformation: case report. AJNR Am J Neuroradiol (2001) 0.84

Complete heart block and seizures in an adult with systemic lupus erythematosus. A possible pathophysiologic role for anti-SS-A/Ro and anti-SS-B/La autoantibodies. Arthritis Rheum (1993) 0.83

Diffusion-weighted MRI in patients with non-diagnostic CT in the post-acute phase of cerebral ischemia. Eur Neurol (2010) 0.83

Prostaglandins activation of erythropoietin production and erythroid progenitor cells. Exp Hematol (1980) 0.83

A stereotactic device for experimental rat and mouse irradiation using gamma knife model B--technical note. Acta Neurochir (Wien) (2001) 0.82

Induction of antigen-specific Th1-biased immune responses by plasmid DNA in schistosoma-infected mice with a preexistent dominant Th2 immune profile. Biochem Biophys Res Commun (2001) 0.82

Immunostimulatory DNA and applications to allergic disease. J Allergy Clin Immunol (1999) 0.82

The potential of flow modification in the treatment of intracranial aneurysms. Interv Neuroradiol (2008) 0.82

Pre-priming: a novel approach to DNA-based vaccination and immunomodulation. Springer Semin Immunopathol (2000) 0.81

Fatal air embolism in pregnancy resulting from an unusual sexual act. Obstet Gynecol (1967) 0.81

Toward an endovascular internal carotid artery classification system. AJNR Am J Neuroradiol (2013) 0.80

Carotid artery plaque classification: does contrast enhancement play a significant role? AJNR Am J Neuroradiol (2012) 0.80

Rapid intracranial clot removal with a new device: the alligator retriever. AJNR Am J Neuroradiol (2007) 0.80

Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler (2011) 0.80

Erythropoietic effects of prostacyclin (PGI2) and its metabolite 6-keto-prostaglandin (PG)E1. J Pharmacol Exp Ther (1983) 0.80

DNA immunization: a novel approach to allergen-specific immunotherapy. Allergy (1997) 0.80

Immunostimulatory DNA inhibits IL-4-dependent IgE synthesis by human B cells. J Allergy Clin Immunol (2001) 0.79

Developmental control by the Drosophila EGF receptor homolog DER. Trends Genet (1992) 0.79

Use of Pipeline Embolization Devices for treatment of a direct carotid-cavernous fistula. Acta Neurochir (Wien) (2015) 0.79

Identification of immunostimulatory DNA-induced genes by suppression subtractive hybridization. Biochem Biophys Res Commun (2001) 0.79

Association between carotid artery plaque type and cerebral microbleeds. AJNR Am J Neuroradiol (2012) 0.79

Angiographic findings associated with intra-axial intracranial tumors. Neuroimaging Clin N Am (1996) 0.79

Induction of remission in a patient with Takayasu's arteritis by low dose pulses of methotrexate. Ann Rheum Dis (1992) 0.78

Angiography of cerebral aneurysms. Neuroimaging Clin N Am (1996) 0.78

Inhibition of IgE antibody formation by plasmid DNA immunization is mediated by both CD4+ and CD8+ T cells. Int Arch Allergy Immunol (1997) 0.78

DNA-Based immunization for asthma. Int Arch Allergy Immunol (1999) 0.78

Evidence for intrathecal synthesis of autoantibodies in systemic lupus erythematosus with neurological involvement. Lupus (1994) 0.78

Arteriovenous fistula of the scalp secondary to punch autograft hair transplantation: angioarchitecture, histopathology, and endovascular and surgical therapy. Plast Reconstr Surg (1997) 0.78

A dissecting aneurysm of the posteroinferior cerebellar artery: case report. Neurosurgery (1998) 0.78

Immunostimulatory sequence oligodeoxynucleotide: A novel mucosal adjuvant. Clin Immunol (2000) 0.78

Transarterial Wedged-catheter, Flow-arrest, N-butyl Cyanoacrylate Embolization of Three Dural Arteriovenous Fistulae in a Single Patient. Interv Neuroradiol (2004) 0.78

Correlates of arterial-filling patterns in the intracarotid amobarbital procedure. Arch Neurol (1995) 0.78

Cardiovascular actions of prostacyclin (PGI2) in the cat. Arch Int Pharmacodyn Ther (1979) 0.78

Solitary focal demyelination in the brain as a paraneoplastic disorder. Med Pediatr Oncol (1996) 0.78

Inhibition of IgE formation and allergic inflammation by allergen gene immunization and by CpG motif immunostimulatory oligodeoxynucleotides. Allergy (1998) 0.78

Gadolinium-enhanced 3D MRA of the aortic arch vessels in the detection of atherosclerotic cerebrovascular occlusive disease. J Comput Assist Tomogr (1998) 0.77

Cerebrovascular accident and myocardial infarction associated with anticardiolipin antibodies in a young woman with systemic lupus erythematosus. Ann Rheum Dis (1989) 0.77

Familial arteriovenous malformations in siblings. Surg Neurol (2000) 0.77

Dropped head syndrome. Neurology (1997) 0.77

Cervical kyphosis after resolution of myopathic head drop. A case report. Spine (Phila Pa 1976) (1996) 0.77

Stroke and cardiac arrest. Neurology (1996) 0.77

Studies on hormonal regulation of the growth of the craniofacial skeleton: II. Effects of a glucocorticoid hormone on sulfate incorporation by neonatal condylar cartilage. J Craniofac Genet Dev Biol (1982) 0.77

Mucosal adjuvanticity of immunostimulatory DNA sequences. Springer Semin Immunopathol (2000) 0.77